Does clofibrate demonstrate Efficacy in In Vitro Treatment of Lymphoma and Multiple Myeloma?
Given the known safety profile and induction of apoptosis at low effective doses, our data warrant further investigation of clofibrate as a novel therapy agent in MM.
Our findings suggest a pathologic role of glutathione depletion in cardiac dysfunction and the therapeutic potential of antioxidants.